Kenneth Ogan MD
- Department of Urology
Professor
- (404) 778-3038
Overview
Dr. Ogan is the Louis McDonald Orr Clinical Professor of Urology at the Emory University School of Medicine and Associate Chief of Urology at Emory University Hospital.
Dr. Ogan attended the University of Vermont, Burlington, VT for his undergraduate education (Bachelor in Art). He received his medical degree from New York Medical College in Valhalla, New York followed by urology residency training at George Washington University School of Medicine. Dr. Ogan completed his fellowship training in endourology, minimally invasive surgery and laparoscopy at the University of Texas Southwestern Medical Center in Dallas, Texas. Dr. Ogan is a diplomate of the American Board of Urology (2003).
Dr. Ogan clinical and research interests lie in minimally invasive therapy including laparoscopic and robotic urologic oncologic (cancer) surgery. He has pioneered various surgical techniques for laparoscopic, robotic and thermal ablation kidney cancer surgery to cure patients from cancer while preserving their kidney function. Dr. Ogan performs robotic surgery for the treatment of kidney, bladder and prostate cancer. Patients attending Emory Urology for cancer treatment have the unique opportunity to be cured of their disease while at the same time preserve their vital organs, their functionality and quality of life. As co-director of the Stone Clinic, Dr. Ogan is also involved in the prevention and endoscopic/percutaneous management of patients with kidney stones.
Dr. Ogan has lectured both nationally and internationally. He is closely involved in teaching and mentoring medical students, urology residents and post-graduate fellows. His research involves the utilization of innovative virtual reality systems to train surgeons to perform surgical procedures. Dr. Ogans innovative work in teaching and training surgeons is well recognized nationally. He is the recipient of the Golden Apple Teaching Award from Emory University Department of Urology in 2008 & 2012. He has authored multiple book chapters and scientific journal articles.
Academic Appointment
- Louis McDonald Orr Clinical Professor Of Urology, Emory University School of Medicine
- Professor, Department of Urology, Emory University School of Medicine
Education
Degrees
- MD from New York Medical College
- BA from University of Vermont
Research
Focus
- My clinical and laboratory efforts have been involved with the minimally invasive treatment of urological diseases. Specifically, I have worked on developing techniques for laparoscopic partial nephrectomy and ablation of small renal tumors. I am also interested in the prevention and endoscopic/percutaneous treatment of kidney stones. Additionally, I have done research on virtual reality systems and training residents to perform urological surgeries.
Publications
-
Incidence of New Mental Health Diagnosis in Testicular Cancer Survivors.
Urology Volume: 200 Page(s): 135 - 141
06/01/2025 Authors: Marthi S; Palmateer G; Helman T; Patil D; Nicaise E; Goodstein T; Ogan K; Narayan V; Master V; Joshi SS -
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.
Nat Cancer Volume: 6 Page(s): 432 - 444
03/01/2025 Authors: Bilen MA; Vo BT; Liu Y; Greenwald R; Davarpanah AH; McGuire D; Shiradkar R; Li L; Midya A; Nazha B -
Paraneoplastic Syndrome Prevalence and Survival in Racially-Diverse Cohort With Renal Cell Carcinoma.
Clin Genitourin Cancer Volume: 22 Page(s): 102207
12/01/2024 Authors: Nicaise EH; Schmeusser BN; Palmateer G; Vashi K; Parikh K; Patil D; Shapiro DD; Abel EJ; Joshi S; Narayan V -
The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature.
Urol Case Rep Volume: 57 Page(s): 102875
11/01/2024 Authors: Palmateer G; Nicaise EH; Gandhi J; Goodstein T; Sheng M; Ogan K; Kucuk O; Yushak M; Sanda MG; Delman KA -
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation.
Cancer Volume: 130 Page(s): 3658 - 3670
11/01/2024 Authors: Martini DJ; Case KB; Gratz D; Pellegrini K; Beagle E; Schneider T; Dababneh M; Nazha B; Brown JT; Joshi SS -
Paraneoplastic Resolution Holds Prognostic Utility in Patients with Metastatic Renal Cell Carcinoma.
Cancers (Basel) Volume: 16
10/30/2024 Authors: Palmateer G; Nicaise EH; Goodstein T; Schmeusser BN; Patil D; Imtiaz N; Shapiro DD; Abel EJ; Joshi S; Narayan V -
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study.
Lancet Oncol Volume: 25 Page(s): 1038 - 1052
08/01/2024 Authors: Allaf ME; Kim S-E; Master V; McDermott DF; Harshman LC; Cole SM; Drake CG; Signoretti S; Akgul M; Baniak N -
Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.
Clin Genitourin Cancer Volume: 22 Page(s): 102056
06/01/2024 Authors: Nicaise EH; Schmeusser BN; Ali A; Midenberg E; Palacios AR; Hartsoe B; Kearns E; Ambadi S; Patil DH; Joshi SS -
Differences in preoperative frailty assessment of surgical candidates by sex, age, and race.
Surg Open Sci Volume: 19 Page(s): 172 - 177
06/01/2024 Authors: Nicaise EH; Palmateer G; Schmeusser BN; Futral C; Liu Y; Goyal S; Nabavizadeh R; Kooby DA; Maithel SK; Sweeney JF -
A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in Drosophila.
Genetics Volume: 226
04/03/2024 Authors: Brockett JS; Manalo T; Zein-Sabatto H; Lee J; Fang J; Chu P; Feng H; Patil D; Davidson P; Ogan K